Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics
PDF) Recurrent refractory Kawasaki disease
Kawasaki Disease | American Academy of Pediatrics
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution
Kawasaki disease is a rare condition. It is most common in children under five years old and most cases occur in children aged between nine months and. - ppt download
Full text] Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Outcomes of the five patients with Kawasaki disease relapse | Download Scientific Diagram
Kawasaki disease
PDF) Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals
2017 AHA Guidelines On Kawasaki Disease – A Link And Excerpts | Tom Wade MD
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
When Should You Suspect Kawasaki Disease as the Cause of Fever in an Infant? | The Hospitalist
Full text] Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics
A case of recurrent Kawasaki disease - ScienceDirect
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram